RTI Biologics (RTIX): Q4 EPS of $0.04 in-line. Revenue of $44.6M (+4% Y/Y) misses by $0.54M. (PR)

|About: RTI Surgical, Inc. (RTIX)|By:, SA News Editor
RTI Biologics (RTIX): Q4 EPS of $0.04 in-line. Revenue of $44.6M (+4% Y/Y) misses by $0.54M. (PR)